Found: 6
Select item for more details and to access through your institution.
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 271, doi. 10.1007/s00262-007-0355-7
- By:
- Publication type:
- Article
A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 4, p. 450, doi. 10.15252/emmm.201404414
- By:
- Publication type:
- Article
Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes.
- Published in:
- Journal of Molecular Medicine, 2010, v. 88, n. 11, p. 1113, doi. 10.1007/s00109-010-0660-z
- By:
- Publication type:
- Article
NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 6, p. 1360, doi. 10.1002/ijc.27792
- By:
- Publication type:
- Article
PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 10, p. 2327, doi. 10.1002/ijc.26272
- By:
- Publication type:
- Article
Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.
- Published in:
- International Journal of Cancer, 2009, v. 125, n. 3, p. 649, doi. 10.1002/ijc.24414
- By:
- Publication type:
- Article